Annual Net Income:
-$74.68M+$65.00M(+46.54%)Summary
- As of April 3, 2025, ITCI annual net profit is -$74.68 million, with the most recent change of +$65.00 million (+46.54%) on December 31, 2024.
- During the last 3 years, ITCI annual net income has risen by +$209.45 million (+73.72%).
- ITCI annual net income is now -350.10% below its all-time high of -$16.59 million, reached on December 31, 2012.
Performance
ITCI Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income:
-$16.89M+$9.44M(+35.86%)Summary
- As of April 3, 2025, ITCI quarterly net profit is -$16.89 million, with the most recent change of +$9.44 million (+35.86%) on December 1, 2024.
- Over the past year, ITCI quarterly net income has stayed the same.
- ITCI quarterly net income is now -154808.26% below its all-time high of -$10.90 thousand, reached on June 30, 2013.
Performance
ITCI Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income:
-$74.68M+$11.69M(+13.54%)Summary
- As of April 3, 2025, ITCI TTM net profit is -$74.68 million, with the most recent change of +$11.69 million (+13.54%) on December 1, 2024.
- Over the past year, ITCI TTM net income has stayed the same.
- ITCI TTM net income is now -685000.92% below its all-time high of -$10.90 thousand, reached on June 30, 2013.
Performance
ITCI TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ITCI Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.5% | 0.0% | 0.0% |
| 3 y3 years | +73.7% | 0.0% | 0.0% |
| 5 y5 years | +49.5% | 0.0% | 0.0% |
ITCI Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +73.7% | -10.7% | +80.5% | at high | +76.8% |
| 5 y | 5-year | at high | +73.7% | -10.7% | +80.5% | at high | +76.8% |
| alltime | all time | -350.1% | +73.7% | <-9999.0% | +80.5% | <-9999.0% | +76.8% |
Intra-Cellular Therapies Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$74.68M(-46.5%) | - | - |
| Dec 2024 | - | -$16.89M(-35.9%) | -$74.68M(-13.5%) |
| Sep 2024 | - | -$26.32M(+62.3%) | -$86.37M(+2.5%) |
| Jun 2024 | - | -$16.22M(+6.4%) | -$84.30M(-24.0%) |
| Mar 2024 | - | -$15.25M(-46.6%) | -$110.87M(-20.6%) |
| Dec 2023 | -$139.67M(-45.5%) | -$28.58M(+17.8%) | -$139.67M(-10.0%) |
| Sep 2023 | - | -$24.26M(-43.3%) | -$155.12M(-15.9%) |
| Jun 2023 | - | -$42.78M(-2.9%) | -$184.37M(-19.2%) |
| Mar 2023 | - | -$44.05M(+0.1%) | -$228.19M(-11.0%) |
| Dec 2022 | -$256.26M(-9.8%) | -$44.03M(-17.7%) | -$256.26M(-14.0%) |
| Sep 2022 | - | -$53.51M(-38.2%) | -$297.96M(-7.3%) |
| Jun 2022 | - | -$86.60M(+20.1%) | -$321.36M(+5.9%) |
| Mar 2022 | - | -$72.12M(-15.9%) | -$303.50M(+6.8%) |
| Dec 2021 | -$284.13M(+25.2%) | -$85.73M(+11.5%) | -$284.13M(+9.7%) |
| Sep 2021 | - | -$76.91M(+11.9%) | -$259.09M(+9.2%) |
| Jun 2021 | - | -$68.74M(+30.3%) | -$237.37M(+2.2%) |
| Mar 2021 | - | -$52.74M(-13.1%) | -$232.34M(+2.3%) |
| Dec 2020 | -$227.01M(+53.7%) | -$60.70M(+10.0%) | -$227.01M(+9.7%) |
| Sep 2020 | - | -$55.18M(-13.4%) | -$206.89M(+10.9%) |
| Jun 2020 | - | -$63.71M(+34.4%) | -$186.57M(+16.4%) |
| Mar 2020 | - | -$47.41M(+16.8%) | -$160.30M(+8.5%) |
| Dec 2019 | -$147.72M | -$40.58M(+16.4%) | -$147.72M(-0.1%) |
| Sep 2019 | - | -$34.86M(-6.9%) | -$147.89M(-4.3%) |
| Jun 2019 | - | -$37.44M(+7.5%) | -$154.55M(+0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$34.84M(-14.5%) | -$154.48M(-0.4%) |
| Dec 2018 | -$155.13M(+58.7%) | -$40.75M(-1.9%) | -$155.13M(+7.3%) |
| Sep 2018 | - | -$41.52M(+11.1%) | -$144.59M(+14.8%) |
| Jun 2018 | - | -$37.38M(+5.3%) | -$125.94M(+18.4%) |
| Mar 2018 | - | -$35.48M(+17.4%) | -$106.32M(+8.7%) |
| Dec 2017 | -$97.77M(-16.0%) | -$30.21M(+32.1%) | -$97.77M(+2.9%) |
| Sep 2017 | - | -$22.87M(+28.8%) | -$95.05M(-7.2%) |
| Jun 2017 | - | -$17.76M(-34.1%) | -$102.44M(-11.3%) |
| Mar 2017 | - | -$26.93M(-2.0%) | -$115.52M(-0.8%) |
| Dec 2016 | -$116.43M(+11.1%) | -$27.48M(-9.2%) | -$116.43M(-1.1%) |
| Sep 2016 | - | -$30.27M(-1.8%) | -$117.78M(-1.6%) |
| Jun 2016 | - | -$30.83M(+10.8%) | -$119.67M(+8.4%) |
| Mar 2016 | - | -$27.84M(-3.4%) | -$110.35M(+5.3%) |
| Dec 2015 | -$104.79M(+241.4%) | -$28.83M(-10.3%) | -$104.79M(+15.0%) |
| Sep 2015 | - | -$32.16M(+49.5%) | -$91.16M(+39.4%) |
| Jun 2015 | - | -$21.51M(-3.5%) | -$65.41M(+35.1%) |
| Mar 2015 | - | -$22.29M(+46.6%) | -$48.43M(+57.8%) |
| Dec 2014 | -$30.69M(+14.2%) | -$15.20M(+136.9%) | -$30.69M(+30.4%) |
| Sep 2014 | - | -$6.42M(+41.5%) | -$23.53M(+6.8%) |
| Jun 2014 | - | -$4.53M(-0.2%) | -$22.03M(+25.8%) |
| Mar 2014 | - | -$4.54M(-43.5%) | -$17.51M(+35.0%) |
| Dec 2013 | -$26.87M(+61.9%) | -$8.04M(+63.7%) | -$12.96M(+163.3%) |
| Sep 2013 | - | -$4.91M(>+9900.0%) | -$4.92M(>+9900.0%) |
| Jun 2013 | - | -$10.90K | -$10.90K |
| Dec 2012 | -$16.59M | - | - |
FAQ
- What is Intra-Cellular Therapies annual net profit?
- What is the all time high annual net income for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual net income year-on-year change?
- What is Intra-Cellular Therapies quarterly net profit?
- What is the all time high quarterly net income for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly net income year-on-year change?
- What is Intra-Cellular Therapies TTM net profit?
- What is the all time high TTM net income for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies TTM net income year-on-year change?
What is Intra-Cellular Therapies annual net profit?
The current annual net income of ITCI is -$74.68M
What is the all time high annual net income for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual net profit is -$16.59M
What is Intra-Cellular Therapies annual net income year-on-year change?
Over the past year, ITCI annual net profit has changed by +$65.00M (+46.54%)
What is Intra-Cellular Therapies quarterly net profit?
The current quarterly net income of ITCI is -$16.89M
What is the all time high quarterly net income for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly net profit is -$10.90K
What is Intra-Cellular Therapies quarterly net income year-on-year change?
Over the past year, ITCI quarterly net profit has changed by $0.00 (0.00%)
What is Intra-Cellular Therapies TTM net profit?
The current TTM net income of ITCI is -$74.68M
What is the all time high TTM net income for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high TTM net profit is -$10.90K
What is Intra-Cellular Therapies TTM net income year-on-year change?
Over the past year, ITCI TTM net profit has changed by $0.00 (0.00%)